Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

51 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Return to fertility after cessation of a continuous oral contraceptive.
Barnhart K, Mirkin S, Grubb G, Constantine G. Barnhart K, et al. Among authors: grubb g. Fertil Steril. 2009 May;91(5):1654-6. doi: 10.1016/j.fertnstert.2008.02.122. Epub 2008 May 7. Fertil Steril. 2009. PMID: 18462723
An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome.
Freeman EW, Halbreich U, Grubb GS, Rapkin AJ, Skouby SO, Smith L, Mirkin S, Constantine GD. Freeman EW, et al. Among authors: grubb gs. Contraception. 2012 May;85(5):437-45. doi: 10.1016/j.contraception.2011.09.010. Epub 2011 Dec 5. Contraception. 2012. PMID: 22152588 Review.
Continuous oral levonorgestrel/ethinyl estradiol for treating premenstrual dysphoric disorder.
Halbreich U, Freeman EW, Rapkin AJ, Cohen LS, Grubb GS, Bergeron R, Smith L, Mirkin S, Constantine GD. Halbreich U, et al. Among authors: grubb gs. Contraception. 2012 Jan;85(1):19-27. doi: 10.1016/j.contraception.2011.05.008. Epub 2011 Jul 13. Contraception. 2012. PMID: 22067793 Clinical Trial.
Metabolic profile of a continuous versus a cyclic low-dose combined oral contraceptive after one year of use.
Rad M, Kluft C, de Kam ML, Meijer P, Cohen AF, Grubb GS, Constantine GD, Burggraaf J. Rad M, et al. Among authors: grubb gs. Eur J Contracept Reprod Health Care. 2011 Apr;16(2):85-94. doi: 10.3109/13625187.2011.556761. Eur J Contracept Reprod Health Care. 2011. PMID: 21417560 Clinical Trial.
Safety and bleeding profile of continuous levonorgestrel 90 mcg/ethinyl estradiol 20 mcg based on 2 years of clinical trial data in Canada.
Reid RL, Fortier MP, Smith L, Mirkin S, Grubb GS, Constantine GD. Reid RL, et al. Among authors: grubb gs. Contraception. 2010 Dec;82(6):497-502. doi: 10.1016/j.contraception.2010.06.002. Epub 2010 Jul 16. Contraception. 2010. PMID: 21074011
Continuous, daily levonorgestrel/ethinyl estradiol vs. 21-day, cyclic levonorgestrel/ethinyl estradiol: efficacy, safety and bleeding in a randomized, open-label trial.
Teichmann A, Apter D, Emerich J, Greven K, Klasa-Mazurkiewicz D, Melis GB, Spaczynski M, Grubb GS, Constantine GD, Spielmann D. Teichmann A, et al. Among authors: grubb gs. Contraception. 2009 Dec;80(6):504-11. doi: 10.1016/j.contraception.2009.05.128. Epub 2009 Aug 6. Contraception. 2009. PMID: 19913143 Clinical Trial.
Ovarian activity and safety of a novel levonorgestrel/ethinyl estradiol continuous oral contraceptive regimen.
Archer DF, Kovalevsky G, Ballagh SA, Grubb GS. Archer DF, et al. Among authors: grubb gs. Contraception. 2009 Sep;80(3):245-53. doi: 10.1016/j.contraception.2009.03.006. Epub 2009 May 2. Contraception. 2009. PMID: 19698816 Clinical Trial.
Occurrence of menses or pregnancy after cessation of a continuous oral contraceptive.
Davis AR, Kroll R, Soltes B, Zhang N, Grubb GS, Constantine GD. Davis AR, et al. Among authors: grubb gs. Fertil Steril. 2008 May;89(5):1059-1063. doi: 10.1016/j.fertnstert.2007.05.012. Epub 2007 Jul 20. Fertil Steril. 2008. PMID: 17658522
Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.
Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD. Archer DF, et al. Among authors: grubb gs. Contraception. 2006 Dec;74(6):439-45. doi: 10.1016/j.contraception.2006.07.005. Epub 2006 Sep 18. Contraception. 2006. PMID: 17157099 Clinical Trial.
Endometrial histology following 1 year of a continuous daily regimen of levonorgestrel 90 micro g/ethinyl estradiol 20 micro g.
Johnson JV, Grubb GS, Constantine GD. Johnson JV, et al. Among authors: grubb gs. Contraception. 2007 Jan;75(1):23-6. doi: 10.1016/j.contraception.2006.07.009. Epub 2006 Sep 7. Contraception. 2007. PMID: 17161119 Clinical Trial.
OBJECTIVE: The objective of this study was to evaluate the effect of a continuous daily regimen of levonorgestrel (LNG) 90 micro g/ethinyl estradiol (EE) 20 micro g on endometrial histology. ...CONCLUSION: The results of a 1-year continuous regimen of LNG 90 micro …
OBJECTIVE: The objective of this study was to evaluate the effect of a continuous daily regimen of levonorgestrel (LNG) 90 micro g/et …
51 results
Jump to page
Feedback